跳转至内容
Merck
  • [Role of rifaximin in correction of IBS-like symptoms in patients with inflammatory bowel disease].

[Role of rifaximin in correction of IBS-like symptoms in patients with inflammatory bowel disease].

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology (2013-12-04)
S S Belous, I L Khalif, O V Golovenko
摘要

One of the important problems in the treatment of patients with inflammatory bowel disease are the persistent complaints of pain, abdominal distention, frequent stools, excretion of mucus with faeces with the presence of endoscopic or roentgenologic remission in the damaged parts of gastrointestinal tract. In this review we describe possible causes of such complaints and some methods of their therapeutic correction.

材料
货号
品牌
产品描述

Sigma-Aldrich
利福昔明
利福昔明, European Pharmacopoeia (EP) Reference Standard
系统适用性试验用利福昔明, European Pharmacopoeia (EP) Reference Standard
Supelco
利福昔明, VETRANAL®, analytical standard